New Drug Approvals: 505(b)(2) Pathway in the USA

If you’ve ever wondered how some drugs reach the US market faster than brand-new molecules, you’re about to uncover one of the smartest regulatory shortcuts—the 505(b)(2) pathway. No, it’s not a loophole.No, it’s not a compromise on safety. Think of

New Drug Approvals: 505(b)(2) Pathway in the USA Read More »